case_images: PMC5337345_01
case_images: TTE revealing the mass on the pulmonary valve.
case_images: CRICC2017-6263578.001.jpg
case_images: PMC5337345_01_CRICC2017-6263578.001.jpg
case_images: fig1
case_images: At day 4, TTE revealed signs of pulmonary hypertension (systolic PAP at 50 mmHg + CVP) and a mass (2 x 3 cm) located on the pulmonary valve, causing moderate pulmonary valve insufficiency estimated at 1.5/4 (Figure 1).
case_images: With the TEE on Doppler mode, we can estimate the tumour's blood flow obstruction in the pulmonary artery.
case_images: CRICC2017-6263578.002.jpg
case_images: PMC5337345_01_CRICC2017-6263578.002.jpg
case_images: fig2
case_images: At this moment, a new (TEE) showed that mass on the pulmonary valve almost completely obstructed the blood flow in the pulmonary artery (Figure 2).
case_images: On the CT scan, the tumour is evaluated at 38.8 mm x 43.5 mm.
case_images: CRICC2017-6263578.003.jpg
case_images: PMC5337345_01_CRICC2017-6263578.003.jpg
case_images: fig3
case_images: It also revealed the presence of a noncompressive pericardial effusion (Figures 3 and 4).
case_images: Illustration of the tumour's heterogeneity in contrast uptake.
case_images: CRICC2017-6263578.004.jpg
case_images: PMC5337345_01_CRICC2017-6263578.004.jpg
case_images: fig4
case_images: It also revealed the presence of a noncompressive pericardial effusion (Figures 3 and 4).